InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by SHREWSBURY STEPHEN B, Directeur Médical. Officer active across 1 companies, notably Impel Neuropharma INC. Cumulatively, 3 disclosures have been logged. The latest transaction was disclosed on 29 March 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations3 total
€43,70424,606 shares@ €1.776146.8% of flow
Common Stock
SEC:0001209191-22-021673:0·
€24,83714,780 shares@ €1.6805100.0% of flow
Common Stock
SEC:0001209191-21-057275·
€24,83714,780 shares@ €1.680526.6% of flow
Common Stock
SEC:0001209191-21-057275:0·
3 of 3 declarations
About SHREWSBURY STEPHEN B
Stephen B. Shrewsbury is the Chief Medical Officer of IMPEL NEUROPHARMA INC. In this role, he is responsible for leading the company's medical and scientific initiatives. With deep expertise in neuropharmacology, he contributes to the innovation and development of new treatments. His leadership is essential in ensuring that IMPEL NEUROPHARMA's products meet the highest standards of safety and efficacy while supporting the company's mission to transform patients' lives.
